Iterum Therapeutics
ITRM
ITRM was delisted on the 31st of March, 2026.
13 hedge funds and large institutions have $31.8M invested in Iterum Therapeutics in 2019 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 3 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
0.4% more ownership
Funds ownership: 2.76% → 3.17% (+0.4%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
8% less capital invested
Capital invested by funds: $34.6M → $31.8M (-$2.82M)
32% less funds holding
Funds holding: 19 → 13 (-6)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
+$72.8K |
| 2 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
+$7.32K |
| 3 |
Morgan Stanley
New York
|
+$6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$2.34M |
| 2 |
Franklin Resources
San Mateo,
California
|
-$1.45M |
| 3 |
Millennium Management
New York
|
-$151K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$2.54K |
ITRM Hedge Fund Activity: Q4 2019 in Review
13 of the 5,009 institutional investors tracked by Wall St. Rank reported a position in Iterum Therapeutics (ITRM) for Q4 2019, worth a combined $31.8M — down 8.1% from $34.6M a quarter earlier.
Fund positioning in ITRM was balanced in Q4 2019: 3 funds opened new positions, 3 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Virtu Financial, opening a new position worth an estimated $72.8K. The largest seller was Cormorant Asset Management, exiting entirely with an estimated $2.34M sold.
- 13 institutional investors held Iterum Therapeutics (ITRM) as of Q4 2019, down from 19 in Q3 2019.
- Funds reported $31.8M of Iterum Therapeutics stock for Q4 2019, down 8.1% quarter-over-quarter.
- 3 funds opened new Iterum Therapeutics positions in Q4 2019 and 3 closed out, a net change of 0 holders.
- The largest Iterum Therapeutics buyer in Q4 2019 was Virtu Financial, an estimated $72.8K added.
- The largest Iterum Therapeutics seller in Q4 2019 was Cormorant Asset Management, an estimated $2.34M sold.
Based on aggregated 13F filings for Q4 2019.